TRUPANION, INC.
Trupanion provides medical insurance for cats and dogs in the United States, Canada and certain countries in Continental Europe. Its subscription business offers direct-to-consumer plans priced according to each pet’s characteristics and coverage level, as well as “Powered by Trupanion” products marketed by third parties. In Canada, it offers Furkin and PHI Direct products, and it sells Trupanion-branded products in Germany and Switzerland. The company also earns revenue from commissions on some products underwritten by third parties. Trupanion’s other business segment primarily underwrites policies for third parties, including Pets Best, the U.S. Department of Veterans Affairs program and employer-sponsored programs. Subscription revenue comes primarily from insurance premiums, while the other segment earns revenue primarily by underwriting policies on behalf of business partners. Trupanion is headquartered in Seattle, Washington.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Trupanion (TRUP) expects double-digit veterinary cost inflation through 2027, with stable rate increases supporting retention. Q3 costs for paying veterinary invoices were $200.6M (69.7% of revenue). Full-year 2026 revenue is projected at $1.59B-$1.597B, with Q4 revenue expected at $407M-$414M. The company repurchased 830,000 shares for $25M and plans new digital insurance and pet food offerings.
Trupanion Inc (TRUP) reported Q3 2026 earnings with record adjusted operating income of $47M, up 15% YoY. Net new pet additions rose 28% YoY to over 20,500, while acquisition cost per pet declined. Retention improved to 98.38%, and free cash flow hit $28.5M. The company is investing in growth initiatives like Landspath pet food, expected to launch in 2027. Challenges include elevated veterinary industry inflation and increased fixed expenses.
TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Third Quarter 2026 Results SEATTLE, WA. November 5, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. “Our third-quart
Over the past 7 days, AlphAI's AI scored 10 news stories mentioning TRUP (TRUPANION, INC.). Coverage has skewed bullish: 9 bullish, 1 neutral, and 0 bearish.
Recent TRUP coverage spans earnings, sector analysis and insider activity.
In the last 30 days, TRUP insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($38K). The most active reporter was GALLAGHER JOHN R, Chief Operating Officer, with 1 filing. 100% of those filings were made under pre-arranged Rule 10b5-1 plans.
Guidance is modestly positive but below prior expectations, likely capping upside.
Strong operating performance and cash generation may support price appreciation.
Strong earnings and buyback suggest upside pressure.
Potential upside as rising pet insurance demand may boost revenue growth.
Earnings setup for TRUP, with consensus revenue growth slowing and investors already positioning around a continued beat.
AlphAI scores every news story that mentions TRUP with an AI model for sentiment and relevance, and aggregates insider trades from TRUPANION, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Trupanion (TRUP) expects double-digit veterinary cost inflation through 2027, with stable rate increases supporting retention. Q3 costs for paying veterinary invoices were $200.6M (69.7% of revenue). Full-year 2026 revenue is projected at $1.59B-$1.597B, with Q4 revenue expected at $407M-$414M. The company repurchased 830,000 shares for $25M and plans new digital insurance and pet food offerings.
Trupanion Inc (TRUP) reported Q3 2026 earnings with record adjusted operating income of $47M, up 15% YoY. Net new pet additions rose 28% YoY to over 20,500, while acquisition cost per pet declined. Retention improved to 98.38%, and free cash flow hit $28.5M. The company is investing in growth initiatives like Landspath pet food, expected to launch in 2027. Challenges include elevated veterinary industry inflation and increased fixed expenses.
TRUPANION, INC. (TRUP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Trupanion Reports Third Quarter 2026 Results SEATTLE, WA. November 5, 2026 -- Trupanion, Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the third quarter ended September 30, 2026. “Our third-quart
Rising veterinary costs, driven by advanced treatments, are increasing pet insurance adoption in the US. About 7 million pets were insured in 2025, up 9% from the previous year. Premiums are projected to reach $6.4 billion in 2026, with average annual veterinary spending at $560. Companies like Embrace Pet Insurance and Trupanion report growing claims and subscriptions. Zoetis and IDEXX Laboratories are among those providing advanced treatments and diagnostics.
Trupanion (TRUP) will report earnings Thursday. Last quarter, it beat revenue expectations with $392.9M (up 11.1% YoY). Analysts expect 9.7% YoY revenue growth this quarter. TRUP shares are up 25.8% in the last month, with an average price target of $33.25.
Essent Group (ESNT) reported Q2 revenues of $362.7M, up 13.6% YoY, beating estimates. Radian Group (RDN) reported $580.7M in revenues, up 95.7% YoY, but missed EPS estimates. Fidelity National Financial (FNF) reported $4.05B in revenues, up 11.4% YoY, beating estimates. W. R. Berkley (WRB) reported $3.72B in revenues, up 1.2% YoY, missing revenue estimates but beating EPS estimates.
Qureshi Fawwad (Chief Financial Officer) sold 6,111 shares of TRUPANION, INC. (TRUP) at $30.01 ($0.18M total) on 2026-08-26.
Trupanion stock fell 6.4% after Piper Sandler downgraded it to Neutral and cut its price target to $32 from $45, citing revenue and margin pressures. Zacks Research also downgraded the stock, amplifying the selloff. The company's shares have retreated from their 52-week high of $46.98, trading near the 52-week low of $21.16.
Trupanion reported Q2 2026 results with net income of $6.83 million and updated revenue guidance, and it announced new partnerships and integrations with Digitail and Home To Home. The article links VetDirect Pay and Exam Day coverage to pet-care workflows and discusses margin and subscription growth targets, including projected $2.0 billion revenue and $36.5 million earnings by 2029.
Trupanion (NASDAQ: TRUP) said it enhanced its free, on-demand Trupanion Certification course for veterinary teams to help them discuss cost-of-care and pet insurance with clients. The company reported 33,800+ professionals from 5,289+ hospitals have completed the program since 2023. The refreshed course adds role-based learning and scenarios. It is available free and awards 0.5 RACE credits.
